The origin and role of innate lymphoid cells in the lung
Open accessThe DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Abstract
Innate lymphoid cells (ILCs), a newly identified member of the lymphoid population, play a critical role in the transition from innate to adaptive immunity in host defense. ILCs are important in mucosal barrier immunity, tissue homeostasis, and immune regulation throughout the body. Significant alterations in ILC responses in lung diseases have been observed and reported. Emerging evidence has shown that ILCs are importantly involved in the pathogenesis and development of a variety of lung diseases, i.e., helminth infections, allergic airway inflammation, and airway hyper-responsiveness. However, as a tissue-resident cell population, the role of ILCs in the lung remains poorly characterized. In this review, we discuss the role of ILCs in lung diseases, the mechanisms underlying the ILC-mediated regulation of immunity, and the therapeutic potential of modulating ILC responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ILCs in the lung interact with epithelial cells, natural killer T cells, and myeloid cells to form an immune system network (122).”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [122]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Hogg, J. C., Chu, F., Utokaparch, S., Woods, R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032158 · Cited by 3,782 · cited 10×
“Importantly, IL-5 and IL-13 were produced by ILC2s and are responsible for COPD exacerbation [111].”
BackgroundInfluentialInnate lymphoid cells — a proposal for uniform nomenclature
Spits, H., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J. P., Eberl, G., Koyasu, S., Locksley, R. M., McKenzie, A. N. J., Mebius, R. E., et al. (2013) · Nature Reviews Immunology · doi:10.1038/nri3365 · Cited by 2,389 · cited 3×
“Compared to adaptive lymphocytes, ILCs are relatively rare in lymphoid tissue, but they populate barrier surfaces, such as the skin, intestine, and lung, as well as in adipose and some mucosal-associated lymphoid tissues [1–3].”
BackgroundInnate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., Furusawa, J.-I., Ohtani, M., Fujii, H., & Koyasu, S. (2010) · Nature · doi:10.1038/nature08636 · Cited by 1,992
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K. A., Bucks, C., Kane, C. M., Fallon, P. G., Pannell, R., et al. (2010) · Nature · doi:10.1038/nature08900 · Cited by 1,938 · cited 3×
“ILC2s regulate antigen-specific T cell responses and enhance T cell cytokine production in an IL-13-independent manner [83].”
BackgroundInfluentialZhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719 · cited 1×
“IL-13 also causes inflammatory responses in monocytes and eosinophils, mucus cell metaplasia, airway fibrosis, and airway obstruction [102].”
BackgroundThe biology of innate lymphoid cells
Artis, D., & Spits, H. (2015) · Nature · doi:10.1038/nature14189 · Cited by 1,634 · cited 1×
“The development of ILCs from CLPs is independent of the RAG-dependent rearrangement of antigen receptors, but is regulated by several transcription factors [3, 17, 18].”
BackgroundHueber, W., Sands, B. E., Lewitzky, S., Vandemeulebroecke, M., Reinisch, W., Higgins, P. D. R., Wehkamp, J., Feagan, B. G., Yao, M. D., Karczewski, M., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301668 · Cited by 1,547 · cited 1×
“In some cases, anti-IL-17 therapy resulted in increased susceptibility to fungal infections and enhanced disease [120–123].”
BackgroundLebrikizumab Treatment in Adults with Asthma
Corren, J., Lemanske, R. F., Hanania, N. A., Korenblat, P. E., Parsey, M. V., Arron, J. R., Harris, J. M., Scheerens, H., Wu, L. C., Su, Z., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106469 · Cited by 1,514 · cited 1×
“Furthermore, antiinterleukin-13 therapy improves the lung function of patients with severe asthma who had a pretreatment profile consistent with interleukin-13 activity [103].”
BackgroundInnate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus
Monticelli, L. A., Sonnenberg, G. F., Abt, M. C., Alenghat, T., Ziegler, C. G. K., Doering, T. A., Angelosanto, J. M., Laidlaw, B. J., Yang, C. Y., Sathaliyawala, T., et al. (2011) · Nature Immunology · doi:10.1038/ni.2131 · Cited by 1,321 · cited 9×
“4-1 % of the total live cells in the lung [8].”
BackgroundInfluentialInnate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus
Monticelli (2011) · PubMed · doi:10.1031/ni.2131 · Cited by 1,286
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity
Cella, M., Fuchs, A., Vermi, W., Facchetti, F., Otero, K., Lennerz, J. K. M., Doherty, J. M., Mills, J. C., & Colonna, M. (2009) · Nature · doi:10.1038/nature07537 · Cited by 1,251 · cited 1×
“ILC3s respond to IL-1β, IL-6, and IL-23; they constitutively express ROR-γt, and they produce the effector cytokines IL-17 and/or IL-22 [50–53].”
BackgroundKatso, R., Okkenhaug, K., Ahmadi, K., White, S., Timms, J., & Waterfield, M. D. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.615 · Cited by 1,204 · cited 1×
“Studies using mouse models indicated that ILCs play an important role in the remodeling of damaged lung tissue following influenza virus infection, contribute to the exacerbated allergic asthma induced by viruses [8–10], promote the release of inflammatory mediators in allergic lung inflammation [11] and are involved…”
MethodMjösberg, J. M., Trifari, S., Crellin, N. K., Peters, C. P., van Drunen, C. M., Piet, B., Fokkens, W. J., Cupedo, T., & Spits, H. (2011) · Nature Immunology · doi:10.1038/ni.2104 · Cited by 1,166 · cited 3×
“ILC2s respond to the cytokines IL-25, IL-33, and thymic stromal lymphopoietin (TSLP); they constitutively express high levels of GATA3; and they produce the effector cytokines IL-4, IL-5, IL-9, IL-13, and amphiregulin [8, 34, 35].”
BackgroundKiessling, R., Klein, E., Pross, H., & Wigzell, H. (1975) · European Journal of Immunology · doi:10.1002/eji.1830050209 · Cited by 1,143 · cited 1×
“The prototypes of the ILCs family are natural killer (NK) cells and lymphoid tissue-inducer (LTi) cells, which were discovered in 1975 and 1997, respectively [5, 6].”
BackgroundEpithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut
Artis, D. (2008) · Nature reviews. Immunology · doi:10.1038/nri2316 · Cited by 1,136 · cited 1×
“spiratory tract mucosal sites is critical to limit exposure to physiological and immunological stimuli [64, 65].”
BackgroundIgE in allergy and asthma today
Gould, H. J., & Sutton, B. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2273 · Cited by 1,136
Systemically dispersed innate IL-13–expressing cells in type 2 immunity
Price, A. E., Liang, H.-E., Sullivan, B. M., Reinhardt, R. L., Eisley, C. J., Erle, D. J., & Locksley, R. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003988107 · Cited by 1,131 · cited 1×
“Studies using mouse models indicated that ILCs play an important role in the remodeling of damaged lung tissue following influenza virus infection, contribute to the exacerbated allergic asthma induced by viruses [8–10], promote the release of inflammatory mediators in allergic lung inflammation [11] and are involved…”
MethodSatoh-Takayama, N., Vosshenrich, C. A. J., Lesjean-Pottier, S., Sawa, S., Lochner, M., Rattis, F., Mention, J.-J., Thiam, K., Cerf-Bensussan, N., Mandelboim, O., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.11.001 · Cited by 1,095 · cited 1×
“ILC3s respond to IL-1β, IL-6, and IL-23; they constitutively express ROR-γt, and they produce the effector cytokines IL-17 and/or IL-22 [50–53].”
BackgroundKlose, C. S. N., Flach, M., Möhle, L., Rogell, L., Hoyler, T., Ebert, K., Fabiunke, C., Pfeifer, D., Sexl, V., Fonseca-Pereira, D., et al. (2014) · Cell · doi:10.1016/j.cell.2014.03.030 · Cited by 1,080 · cited 10×
“All ILCs develop from CLPs, which can differentiate into NKps or CHILPs.”
BackgroundInfluentialInnate lymphoid cells drive interleukin-23-dependent innate intestinal pathology
Buonocore, S., Ahern, P. P., Uhlig, H. H., Ivanov, I. I., Littman, D. R., Maloy, K. J., & Powrie, F. (2010) · Nature · doi:10.1038/nature08949 · Cited by 1,067
Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues
Bernink, J. H., Peters, C. P., Munneke, M., te Velde, A. A., Meijer, S. L., Weijer, K., Hreggvidsdottir, H. S., Heinsbroek, S. E., Legrand, N., Buskens, C. J., et al. (2013) · Nature Immunology · doi:10.1038/ni.2534 · Cited by 1,006 · cited 15×
“Another subset of ILC1s, CD103+ intraepithelial ILC1s, develop from an as yet unknown precursor in a process that requires T-bet, NFIL3, and Id2, but not IL-15; ILC1s express Eomes [33].”
BackgroundInfluentialGroup 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity
Brestoff, J. R., Kim, B. S., Saenz, S. A., Stine, R. R., Monticelli, L. A., Sonnenberg, G. F., Thome, J. J., Farber, D. L., Lutfy, K., Seale, P., et al. (2015) · Nature · doi:10.1038/nature14115 · Cited by 968 · cited 1×
“Mature ILC2s populate the healthy skin, lungs, and adipose tissue of humans and mice [8, 34, 35, 45–48], and they are the most common group in the lung [49].”
BackgroundHalim, T. Y. F., Steer, C. A., Mathä, L., Gold, M. J., Martinez-Gonzalez, I., McNagny, K. M., McKenzie, A. N. J., & Takei, F. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.011 · Cited by 949 · cited 1×
“This occurs either by migration of activated DCs to the lung draining lymph node and subsequent Th2 cell priming in response to IL-13 [85] or by the direct interactions with CD4 T cells in a major histocompatibility complex class II (MHCII)-dependent manner [86, 87].”
BackgroundBrodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
Papp, K. A., Leonardi, C., Menter, A., Ortonne, J.-P., Krueger, J. G., Kricorian, G., Aras, G., Li, J., Russell, C. B., Thompson, E. H. Z., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109017 · Cited by 941 · cited 1×
“Many anti-Interleukin-17 or anti-Interleukin-23 receptor antibodies, which target the IL-23-IL-17 pathway, have beneficial effects on psoriasis and rheumatoid arthritis in experimental mouse models and patients [114–119].”
BackgroundKuperman, D. A., Huang, X., Koth, L. L., Chang, G. H., Dolganov, G. M., Zhu, Z., Elias, J. A., Sheppard, D., & Erle, D. J. (2002) · Nature Medicine · doi:10.1038/nm734 · Cited by 937 · cited 1×
“were known to promote mucus production and tissue repair [66, 70].”
BackgroundAnti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 936 · cited 1×
“Many anti-Interleukin-17 or anti-Interleukin-23 receptor antibodies, which target the IL-23-IL-17 pathway, have beneficial effects on psoriasis and rheumatoid arthritis in experimental mouse models and patients [114–119].”
BackgroundFuchs, A., Vermi, W., Lee, J. S., Lonardi, S., Gilfillan, S., Newberry, R. D., Cella, M., & Colonna, M. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.010 · Cited by 907
Molofsky, A. B., Nussbaum, J. C., Liang, H.-E., Van Dyken, S. J., Cheng, L. E., Mohapatra, A., Chawla, A., & Locksley, R. M. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121964 · Cited by 874 · cited 1×
“Mature ILC2s populate the healthy skin, lungs, and adipose tissue of humans and mice [8, 34, 35, 45–48], and they are the most common group in the lung [49].”
BackgroundThe Aryl Hydrocarbon Receptor Regulates Gut Immunity through Modulation of Innate Lymphoid Cells
Qiu, J., Heller, J. J., Guo, X., Chen, Z.-M. E., Fish, K., Fu, Y.-X., & Zhou, L. (2012) · Immunity · doi:10.1016/j.immuni.2011.11.011 · Cited by 859 · cited 1×
“These cells can express IFN-γ and IL-22, and their development requires T-bet and Ahr [54–58].”
BackgroundThe Transcription Factor GATA-3 Controls Cell Fate and Maintenance of Type 2 Innate Lymphoid Cells
Hoyler, T., Klose, C. S. N., Souabni, A., Turqueti-Neves, A., Pfeifer, D., Rawlins, E. L., Voehringer, D., Busslinger, M., & Diefenbach, A. (2012) · Immunity · doi:10.1016/j.immuni.2012.06.020 · Cited by 852 · cited 1×
“Furthermore, GATA3 is required for the functional maturation and maintenance of ILC2s [41–44], and Bcl11b serves as a upstream regulator of the transcriptional factor Gfi1 to maintain Gfi1 expression in mature ILC2s.”
BackgroundA committed precursor to innate lymphoid cells
Constantinides, M. G., McDonald, B. D., Verhoef, P. A., & Bendelac, A. (2014) · Nature · doi:10.1038/nature13047 · Cited by 816
Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs
Gasteiger, G., Fan, X., Dikiy, S., Lee, S. Y., & Rudensky, A. Y. (2015) · Science · doi:10.1126/science.aac9593 · Cited by 810 · cited 3×
“Mature ILC2s populate the healthy skin, lungs, and adipose tissue of humans and mice [8, 34, 35, 45–48], and they are the most common group in the lung [49].”
BackgroundHalim, T. Y. F., Krauß, R. H., Sun, A. C., & Takei, F. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.020 · Cited by 804 · cited 1×
“Other studies showed that FALC-derived ILC2s support the self-renewal and expansion of B1 and B2 cells and enhance the production of the IgA, IgM, IgG1, and IgE antibody classes [34, 71, 72, 91].”
BackgroundNatural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles
Kiss, E. A., Vonarbourg, C., Kopfmann, S., Hobeika, E., Finke, D., Esser, C., & Diefenbach, A. (2011) · Science · doi:10.1126/science.1214914 · Cited by 801 · cited 1×
“These cells can express IFN-γ and IL-22, and their development requires T-bet and Ahr [54–58].”
BackgroundChang, Y.-J., Kim, H. Y., Albacker, L. A., Baumgarth, N., McKenzie, A. N. J., Smith, D. E., DeKruyff, R. H., & Umetsu, D. T. (2011) · Nature Immunology · doi:10.1038/ni.2045 · Cited by 777 · cited 3×
“For example, epithelial cell- or myeloid cell-derived IL-25, IL-33, and TSLP can elicit ILC2 responses after allergen, chemical, or helminth parasite exposure or influenza virus infection [8, 9, 34, 35, 46, 71–73].”
BackgroundMethodLee, J. S., Cella, M., McDonald, K. G., Garlanda, C., Kennedy, G. D., Nukaya, M., Mantovani, A., Kopan, R., Bradfield, C. A., Newberry, R. D., et al. (2012) · Nature Immunology · doi:10.1038/ni.2187 · Cited by 777 · cited 1×
“These cells can express IFN-γ and IL-22, and their development requires T-bet and Ahr [54–58].”
BackgroundTSLP Elicits IL-33–Independent Innate Lymphoid Cell Responses to Promote Skin Inflammation
Kim, B. S., Siracusa, M. C., Saenz, S. A., Noti, M., Monticelli, L. A., Sonnenberg, G. F., Hepworth, M. R., Van Voorhees, A. S., Comeau, M. R., & Artis, D. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005374 · Cited by 731 · cited 2×
“Mature ILC2s populate the healthy skin, lungs, and adipose tissue of humans and mice [8, 34, 35, 45–48], and they are the most common group in the lung [49].”
BackgroundA T-bet gradient controls the fate and function of CCR6−RORγt+ innate lymphoid cells
Klose, C. S. N., Kiss, E. A., Schwierzeck, V., Ebert, K., Hoyler, T., d’Hargues, Y., Göppert, N., Croxford, A. L., Waisman, A., Tanriver, Y., et al. (2013) · Nature · doi:10.1038/nature11813 · Cited by 719
The Transcription Factor PLZF Directs the Effector Program of the NKT Cell Lineage
Savage, A. K., Constantinides, M. G., Han, J., Picard, D., Martin, E., Li, B., Lantz, O., & Bendelac, A. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.011 · Cited by 716 · cited 1×
“ILCps transiently express abundant PLZF, a transcription factor associated with NKT cell development [29, 30], suggesting an interaction between ILCps and NKT cells.”
BackgroundThe IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1
Cayrol, C., & Girard, J.-P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812690106 · Cited by 707 · cited 1×
“IL-33 is a chromatin-associated nuclear cytokine that is abundantly expressed in epithelial and endothelial cells and thought to be released only upon cellular damage or necrotic cell death [76, 77].”
BackgroundEpithelial repair mechanisms in the lung
Crosby, L. M., & Waters, C. M. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00361.2009 · Cited by 705 · cited 2×
“tissue fibrosis [94, 95].”
BackgroundOliphant, C. J., Hwang, Y. Y., Walker, J. A., Salimi, M., Wong, S. H., Brewer, J. M., Englezakis, A., Barlow, J. L., Hams, E., Scanlon, S. T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.016 · Cited by 696
Mebius, R. E., Rennert, P., & Weissman, I. L. (1997) · Immunity · doi:10.1016/s1074-7613(00)80371-4 · Cited by 693 · cited 1×
“The prototypes of the ILCs family are natural killer (NK) cells and lymphoid tissue-inducer (LTi) cells, which were discovered in 1975 and 1997, respectively [5, 6].”
BackgroundInnate Lymphoid Cells: Emerging Insights in Development, Lineage Relationships, and Function
Spits, H., & Cupedo, T. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075053 · Cited by 693 · cited 1×
“Compared to typical lymphoid cells, ILCs are characterized by three main features: 1) the absence of recombination activating gene (RAG)-dependent rearrangement of antigen receptors; 2) a lack of phenotypical markers of myeloid cells and dendritic cells; and 3) particular lymphoid morphology [4].”
BackgroundVonarbourg, C., Mortha, A., Bui, V. L., Hernandez, P. P., Kiss, E. A., Hoyler, T., Flach, M., Bengsch, B., Thimme, R., Hölscher, C., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.017 · Cited by 676
Innate lymphoid cells — how did we miss them?
Walker, J. A., Barlow, J. L., & McKenzie, A. N. J. (2013) · Nature Reviews Immunology · doi:10.1038/nri3349 · Cited by 669 · cited 1×
“The development of ILCs from CLPs is independent of the RAG-dependent rearrangement of antigen receptors, but is regulated by several transcription factors [3, 17, 18].”
BackgroundHuang, Y., Guo, L., Qiu, J., Chen, X., Hu-Li, J., Siebenlist, U., Williamson, P. R., Urban, J. F., & Paul, W. E. (2015) · Nature Immunology · doi:10.1038/ni.3078 · Cited by 646 · cited 1×
“The ILC2 population can differentiate into IL17-producing ILC3-like cells [61].”
BackgroundThe Transcription Factor GATA3 Is Essential for the Function of Human Type 2 Innate Lymphoid Cells
Mjösberg, J., Bernink, J., Golebski, K., Karrich, J. J., Peters, C. P., Blom, B., te Velde, A. A., Fokkens, W. J., van Drunen, C. M., & Spits, H. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.015 · Cited by 636 · cited 1×
“Furthermore, GATA3 is required for the functional maturation and maintenance of ILC2s [41–44], and Bcl11b serves as a upstream regulator of the transcriptional factor Gfi1 to maintain Gfi1 expression in mature ILC2s.”
BackgroundKim, H. Y., Lee, H. J., Chang, Y.-J., Pichavant, M., Shore, S. A., Fitzgerald, K. A., Iwakura, Y., Israel, E., Bolger, K., Faul, J., et al. (2014) · Nature Medicine · doi:10.1038/nm.3423 · Cited by 635 · cited 2×
“Furthermore, although ILC3s are normally absent in the lungs of healthy mice [8], in the lungs of a mouse model of obesity-induced asthma, ILC3s expand in response to NLRP3-dependent production of IL-1β by macrophages [63].”
Transcription factor RORα is critical for nuocyte development
Wong, S. H., Walker, J. A., Jolin, H. E., Drynan, L. F., Hams, E., Camelo, A., Barlow, J. L., Neill, D. R., Panova, V., Koch, U., et al. (2012) · Nature Immunology · doi:10.1038/ni.2208 · Cited by 576
CD4+ Lymphoid Tissue-Inducer Cells Promote Innate Immunity in the Gut
Sonnenberg, G. F., Monticelli, L. A., Elloso, M. M., Fouser, L. A., & Artis, D. (2011) · Immunity · doi:10.1016/j.immuni.2010.12.009 · Cited by 572 · cited 1×
“ILC3s respond to IL-1β, IL-6, and IL-23; they constitutively express ROR-γt, and they produce the effector cytokines IL-17 and/or IL-22 [50–53].”
BackgroundDevelopment, Differentiation, and Diversity of Innate Lymphoid Cells
Diefenbach, A., Colonna, M., & Koyasu, S. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.005 · Cited by 560 · cited 1×
“The development of ILCs from CLPs is independent of the RAG-dependent rearrangement of antigen receptors, but is regulated by several transcription factors [3, 17, 18].”
BackgroundKovalovsky, D., Uche, O. U., Eladad, S., Hobbs, R. M., Yi, W., Alonzo, E., Chua, K., Eidson, M., Kim, H.-J., Im, J. S., et al. (2008) · Nature Immunology · doi:10.1038/ni.1641 · Cited by 557
Bartemes, K. R., Iijima, K., Kobayashi, T., Kephart, G. M., McKenzie, A. N., & Kita, H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102832 · Cited by 549 · cited 2×
“Other studies showed that FALC-derived ILC2s support the self-renewal and expansion of B1 and B2 cells and enhance the production of the IgA, IgM, IgG1, and IgE antibody classes [34, 71, 72, 91].”
BackgroundInnate lymphoid cells in the initiation, regulation and resolution of inflammation
Sonnenberg, G. F., & Artis, D. (2015) · Nature Medicine · doi:10.1038/nm.3892 · Cited by 503 · cited 1×
“1) [2, 7].”
Lineage Relationship Analysis of RORγt + Innate Lymphoid Cells
Sawa, S., Cherrier, M., Lochner, M., Satoh-Takayama, N., Fehling, H. J., Langa, F., Di Santo, J. P., & Eberl, G. (2010) · Science · doi:10.1126/science.1194597 · Cited by 502 · cited 1×
“ILC3s respond to IL-1β, IL-6, and IL-23; they constitutively express ROR-γt, and they produce the effector cytokines IL-17 and/or IL-22 [50–53].”
BackgroundAn IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation
Wilhelm, C., Hirota, K., Stieglitz, B., Van Snick, J., Tolaini, M., Lahl, K., Sparwasser, T., Helmby, H., & Stockinger, B. (2011) · Nature Immunology · doi:10.1038/ni.2133 · Cited by 481
Barlow, J. L., Bellosi, A., Hardman, C. S., Drynan, L. F., Wong, S. H., Cruickshank, J. P., & McKenzie, A. N. J. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.09.041 · Cited by 474 · cited 1×
“mucus hypersecretion and inflammation [100, 101].”
Wolterink, R. G. J. K., KleinJan, A., van Nimwegen, M., Bergen, I., de Bruijn, M., Levani, Y., & Hendriks, R. W. (2012) · European Journal of Immunology · doi:10.1002/eji.201142018 · Cited by 473 · cited 1×
“allergic asthma [99].”
Genovese, M. C., Van den Bosch, F., Roberson, S. A., Bojin, S., Biagini, I. M., Ryan, P., & Sloan‐Lancaster, J. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27334 · Cited by 451 · cited 1×
“Many anti-Interleukin-17 or anti-Interleukin-23 receptor antibodies, which target the IL-23-IL-17 pathway, have beneficial effects on psoriasis and rheumatoid arthritis in experimental mouse models and patients [114–119].”
BackgroundLipoxin A 4 Regulates Natural Killer Cell and Type 2 Innate Lymphoid Cell Activation in Asthma
Barnig, C., Cernadas, M., Dutile, S., Liu, X., Perrella, M. A., Kazani, S., Wechsler, M. E., Israel, E., & Levy, B. D. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004812 · Cited by 448 · cited 3×
“In humans, mast cells can promote ILC2 responses directly by producing prostaglandin D2 (PGD2) [75].”
BackgroundBeagley, K. W., Eldridge, J. H., Lee, F., Kiyono, H., Everson, M. P., Koopman, W. J., Hirano, T., Kishimoto, T., & McGhee, J. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.6.2133 · Cited by 447
Epithelial Progenitor Cells in Lung Development, Maintenance, Repair, and Disease
Rock, J. R., & Hogan, B. L. M. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100109-104040 · Cited by 416 · cited 2×
“tissue fibrosis [94, 95].”
BackgroundLi, D., Guabiraba, R., Besnard, A.-G., Komai-Koma, M., Jabir, M. S., Zhang, L., Graham, G. J., Kurowska-Stolarska, M., Liew, F. Y., McSharry, C., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.05.011 · Cited by 413
Sonoda, E., Matsumoto, R., Hitoshi, Y., Ishii, T., Sugimoto, M., Araki, S., Tominaga, A., Yamaguchi, N., & Takatsu, K. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.4.1415 · Cited by 399
Turner, J.-E., Morrison, P. J., Wilhelm, C., Wilson, M., Ahlfors, H., Renauld, J.-C., Panzer, U., Helmby, H., & Stockinger, B. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130071 · Cited by 397
Critical Role for IL-13 in the Development of Allergen-Induced Airway Hyperreactivity
Walter, D. M., McIntire, J. J., Berry, G., McKenzie, A. N. J., Donaldson, D. D., DeKruyff, R. H., & Umetsu, D. T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4668 · Cited by 396 · cited 1×
“mucus hypersecretion and inflammation [100, 101].”
Moro, K., Kabata, H., Tanabe, M., Koga, S., Takeno, N., Mochizuki, M., Fukunaga, K., Asano, K., Betsuyaku, T., & Koyasu, S. (2016) · Nature Immunology · doi:10.1038/ni.3309 · Cited by 393 · cited 1×
“The transcription factor STAT1 seems important in mediating the suppressive effects of IL-27 and IFN-γ on ILC2 functions [92, 93].”
BackgroundHalim, T. Y. F., MacLaren, A., Romanish, M. T., Gold, M. J., McNagny, K. M., & Takei, F. (2012) · Immunity · doi:10.1016/j.immuni.2012.06.012 · Cited by 391 · cited 9×
“ILC3s include all ILC subtypes that produce IL-17 and/or IL-22, and they depend on the transcription factor ROR-γt for their development and function (Fig.”
BackgroundInfluentialGladiator, A., Wangler, N., Trautwein-Weidner, K., & LeibundGut-Landmann, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202924 · Cited by 382 · cited 1×
“Many anti-Interleukin-17 or anti-Interleukin-23 receptor antibodies, which target the IL-23-IL-17 pathway, have beneficial effects on psoriasis and rheumatoid arthritis in experimental mouse models and patients [114–119].”
BackgroundYagi, R., Zhong, C., Northrup, D. L., Yu, F., Bouladoux, N., Spencer, S., Hu, G., Barron, L., Sharma, S., Nakayama, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.012 · Cited by 379
IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis
Hams, E., Armstrong, M. E., Barlow, J. L., Saunders, S. P., Schwartz, C., Cooke, G., Fahy, R. J., Crotty, T. B., Hirani, N., Flynn, R. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315854111 · Cited by 376 · cited 1×
“Studies using mouse models indicated that ILCs play an important role in the remodeling of damaged lung tissue following influenza virus infection, contribute to the exacerbated allergic asthma induced by viruses [8–10], promote the release of inflammatory mediators in allergic lung inflammation [11] and are involved…”
MethodKabata, H., Moro, K., Fukunaga, K., Suzuki, Y., Miyata, J., Masaki, K., Betsuyaku, T., Koyasu, S., & Asano, K. (2013) · Nature Communications · doi:10.1038/ncomms3675 · Cited by 348 · cited 1×
“For example, epithelial cell- or myeloid cell-derived IL-25, IL-33, and TSLP can elicit ILC2 responses after allergen, chemical, or helminth parasite exposure or influenza virus infection [8, 9, 34, 35, 46, 71–73].”
BackgroundPowell, N., Walker, A. W., Stolarczyk, E., Canavan, J. B., Gökmen, M. R., Marks, E., Jackson, I., Hashim, A., Curtis, M. A., Jenner, R. G., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.09.008 · Cited by 324 · cited 1×
“However, ILC3s with a unique phenotype, which express Thy1, stem cell antigen 1 (SCA-1), ROR-γt and IL23R, can develop in some inflammatory contexts in the liver and intestine [59, 60].”
BackgroundDuerr, C. U., McCarthy, C. D. A., Mindt, B. C., Rubio, M., Meli, A. P., Pothlichet, J., Eva, M. M., Gauchat, J.-F., Qureshi, S. T., Mazer, B. D., et al. (2016) · Nature Immunology · doi:10.1038/ni.3308 · Cited by 324 · cited 2×
“The transcription factor STAT1 seems important in mediating the suppressive effects of IL-27 and IFN-γ on ILC2 functions [92, 93].”
BackgroundTakatsu, K., & Nakajima, H. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.04.001 · Cited by 320 · cited 1×
“IL-4 induces IgE production by B cells [97], IL-5 activates eosinophils and recruits them to the lung [98], and IL13 increases mucus production [98].”
BackgroundKim, H. Y., Chang, Y.-J., Subramanian, S., Lee, H.-H., Albacker, L. A., Matangkasombut, P., Savage, P. B., McKenzie, A. N. J., Smith, D. E., Rottman, J. B., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.10.036 · Cited by 316 · cited 1×
“Recent studies have shown that IL-33 is also expressed by NKT cells, alveolar macrophages, DCs, and mast cells [9, 80–82].”
BackgroundMotomura, Y., Morita, H., Moro, K., Nakae, S., Artis, D., Endo, T. A., Kuroki, Y., Ohara, O., Koyasu, S., & Kubo, M. (2014) · Immunity · doi:10.1016/j.immuni.2014.04.013 · Cited by 308
Type 2 Innate Lymphoid Cells Drive CD4+ Th2 Cell Responses
Mirchandani, A. S., Besnard, A.-G., Yip, E., Scott, C., Bain, C. C., Cerovic, V., Salmond, R. J., & Liew, F. Y. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300974 · Cited by 302 · cited 1×
“This occurs either by migration of activated DCs to the lung draining lymph node and subsequent Th2 cell priming in response to IL-13 [85] or by the direct interactions with CD4 T cells in a major histocompatibility complex class II (MHCII)-dependent manner [86, 87].”
BackgroundInnate Lymphoid Cell Interactions with Microbiota: Implications for Intestinal Health and Disease
Sonnenberg, G. F., & Artis, D. (2012) · Immunity · doi:10.1016/j.immuni.2012.10.003 · Cited by 277 · cited 2×
“Compared to adaptive lymphocytes, ILCs are relatively rare in lymphoid tissue, but they populate barrier surfaces, such as the skin, intestine, and lung, as well as in adipose and some mucosal-associated lymphoid tissues [1–3].”
BackgroundGeiger, T. L., Abt, M. C., Gasteiger, G., Firth, M. A., O’Connor, M. H., Geary, C. D., O’Sullivan, T. E., van den Brink, M. R., Pamer, E. G., Hanash, A. M., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140212 · Cited by 269 · cited 1×
“The differentiation of ILCs from CLPs requires transcriptional factors, including inhibitor of DNA binding 2 (Id2), nuclear factor interleukin-3 regulated (NFIL3), and thymocyte selection-associated highmobility group box protein (TOX) [2, 3, 16, 19–24].”
BackgroundNfil3 is required for the development of all innate lymphoid cell subsets
Seillet, C., Rankin, L. C., Groom, J. R., Mielke, L. A., Tellier, J., Chopin, M., Huntington, N. D., Belz, G. T., & Carotta, S. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140145 · Cited by 251 · cited 1×
“The differentiation of ILCs from CLPs requires transcriptional factors, including inhibitor of DNA binding 2 (Id2), nuclear factor interleukin-3 regulated (NFIL3), and thymocyte selection-associated highmobility group box protein (TOX) [2, 3, 16, 19–24].”
BackgroundNotch signaling is necessary for adult, but not fetal, development of RORγt+ innate lymphoid cells
Possot, C., Schmutz, S., Chea, S., Boucontet, L., Louise, A., Cumano, A., & Golub, R. (2011) · Nature Immunology · doi:10.1038/ni.2105 · Cited by 246
T Cell Factor 1 Is Required for Group 2 Innate Lymphoid Cell Generation
Yang, Q., Monticelli, L. A., Saenz, S. A., Chi, A. W.-S., Sonnenberg, G. F., Tang, J., De Obaldia, M. E., Bailis, W., Bryson, J. L., Toscano, K., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.003 · Cited by 244 · cited 1×
“NKps develop into NK cells, and CHILPs give rise to all other ILCs through a process that requires T-cell factor 1 (TCF1), interleukin 7 (IL-7) [24] and GATA3 [25–28].”
BackgroundYu, X., Wang, Y., Deng, M., Li, Y., Ruhn, K. A., Zhang, C. C., & Hooper, L. V. (2014) · eLife · doi:10.7554/elife.04406 · Cited by 244
Cherrier, M., Sawa, S., & Eberl, G. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111594 · Cited by 243
IL-33 Is Produced by Mast Cells and Regulates IgE-Dependent Inflammation
Hsu, C.-L., Neilsen, C. V., & Bryce, P. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011944 · Cited by 236 · cited 1×
“Recent studies have shown that IL-33 is also expressed by NKT cells, alveolar macrophages, DCs, and mast cells [9, 80–82].”
BackgroundHams, E., Locksley, R. M., McKenzie, A. N. J., & Fallon, P. G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301176 · Cited by 232 · cited 1×
“Mature ILC2s populate the healthy skin, lungs, and adipose tissue of humans and mice [8, 34, 35, 45–48], and they are the most common group in the lung [49].”
BackgroundKlein Wolterink, R. G. J., Serafini, N., van Nimwegen, M., Vosshenrich, C. A. J., de Bruijn, M. J. W., Fonseca Pereira, D., Veiga Fernandes, H., Hendriks, R. W., & Di Santo, J. P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217158110 · Cited by 226 · cited 1×
“Furthermore, GATA3 is required for the functional maturation and maintenance of ILC2s [41–44], and Bcl11b serves as a upstream regulator of the transcriptional factor Gfi1 to maintain Gfi1 expression in mature ILC2s.”
BackgroundGata3 drives development of RORγt+ group 3 innate lymphoid cells
Serafini, N., Klein Wolterink, R. G. J., Satoh-Takayama, N., Xu, W., Vosshenrich, C. A. J., Hendriks, R. W., & Di Santo, J. P. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131038 · Cited by 203
Dual Role of IL-22 in Allergic Airway Inflammation and its Cross-talk with IL-17A
Besnard, A.-G., Sabat, R., Dumoutier, L., Renauld, J.-C., Willart, M., Lambrecht, B., Teixeira, M. M., Charron, S., Fick, L., Erard, F., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201008-1383oc · Cited by 201
Mohapatra, A., Van Dyken, S. J., Schneider, C., Nussbaum, J. C., Liang, H.-E., & Locksley, R. M. (2016) · Mucosal Immunology · doi:10.1038/mi.2015.59 · Cited by 199 · cited 2×
“13, which are required for optimal epithelial responses in the conducting airways [69].”
BackgroundMethodSeehus, C. R., Aliahmad, P., de la Torre, B., Iliev, I. D., Spurka, L., Funari, V. A., & Kaye, J. (2015) · Nature Immunology · doi:10.1038/ni.3168 · Cited by 191 · cited 1×
“The differentiation of ILCs from CLPs requires transcriptional factors, including inhibitor of DNA binding 2 (Id2), nuclear factor interleukin-3 regulated (NFIL3), and thymocyte selection-associated highmobility group box protein (TOX) [2, 3, 16, 19–24].”
BackgroundWills-Karp, M., Rani, R., Dienger, K., Lewkowich, I., Fox, J. G., Perkins, C., Lewis, L., Finkelman, F. D., Smith, D. E., Bryce, P. J., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20110079 · Cited by 191 · cited 1×
“were known to promote mucus production and tissue repair [66, 70].”
BackgroundGroup 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice
Montaldo, E., Juelke, K., & Romagnani, C. (2015) · European Journal of Immunology · doi:10.1002/eji.201545598 · Cited by 190 · cited 1×
“Additionally, IL-17A and IL-22, which are produced by NCR ILC3s, contribute to the formation of lymphoid follicles [107, 108].”
BackgroundNFIL3 Orchestrates the Emergence of Common Helper Innate Lymphoid Cell Precursors
Xu, W., Domingues, R. G., Fonseca-Pereira, D., Ferreira, M., Ribeiro, H., Lopez-Lastra, S., Motomura, Y., Moreira-Santos, L., Bihl, F., Braud, V., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.057 · Cited by 184 · cited 5×
“The differentiation of ILC1s from ILCps requires eomesodermin (Eomes), T-bet, IL-15, and IL-7.”
BackgroundInfluentialSpecification of type 2 innate lymphocytes by the transcriptional determinant Gfi1
Spooner, C. J., Lesch, J., Yan, D., Khan, A. A., Abbas, A., Ramirez-Carrozzi, V., Zhou, M., Soriano, R., Eastham-Anderson, J., Diehl, L., et al. (2013) · Nature Immunology · doi:10.1038/ni.2743 · Cited by 176 · cited 1×
“ILC2 development requires GATA3 [27, 28], ROR-α [36, 37], and the transcription factors Gfi1 and Bcl11b [38–40].”
BackgroundCharacterization and Quantification of Innate Lymphoid Cell Subsets in Human Lung
De Grove, K. C., Provoost, S., Verhamme, F. M., Bracke, K. R., Joos, G. F., Maes, T., & Brusselle, G. G. (2016) · PLOS ONE · doi:10.1371/journal.pone.0145961 · Cited by 170 · cited 2×
“A tendency toward a higher frequency of NCR ILC3 was observed in the lungs of patients with COPD compared with the controls [62].”
BackgroundResultPouwels, S. D., Zijlstra, G. J., van der Toorn, M., Hesse, L., Gras, R., ten Hacken, N. H. T., Krysko, D. V., Vandenabeele, P., de Vries, M., van Oosterhout, A. J. M., et al. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00174.2015 · Cited by 166 · cited 1×
“Neutrophil elastase and IL-5 levels are increased in AECOPD patients [109].”
BackgroundBcl11b is essential for group 2 innate lymphoid cell development
Walker, J. A., Oliphant, C. J., Englezakis, A., Yu, Y., Clare, S., Rodewald, H.-R., Belz, G., Liu, P., Fallon, P. G., & McKenzie, A. N. J. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142224 · Cited by 165 · cited 1×
“ILC2 development requires GATA3 [27, 28], ROR-α [36, 37], and the transcription factors Gfi1 and Bcl11b [38–40].”
BackgroundYu, Y., Wang, C., Clare, S., Wang, J., Lee, S.-C., Brandt, C., Burke, S., Lu, L., He, D., Jenkins, N. A., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142318 · Cited by 162 · cited 1×
“ILC2 development requires GATA3 [27, 28], ROR-α [36, 37], and the transcription factors Gfi1 and Bcl11b [38–40].”
BackgroundHuman RORγt+CD34+ Cells Are Lineage-Specified Progenitors of Group 3 RORγt+ Innate Lymphoid Cells
Montaldo, E., Teixeira-Alves, L. G., Glatzer, T., Durek, P., Stervbo, U., Hamann, W., Babic, M., Paclik, D., Stölzel, K., Gröne, J., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.11.010 · Cited by 158
Gorski, S. A., Hahn, Y. S., & Braciale, T. J. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003615 · Cited by 157 · cited 1×
“During influenza virus infection in mice, enhanced release of IL-33 from NKT cells occurred concomitantly with enhanced IL-5 production by ILC2s [82].”
BackgroundDenney, L., Byrne, A. J., Shea, T. J., Buckley, J. S., Pease, J. E., Herledan, G. M. F., Walker, S. A., Gregory, L. G., & Lloyd, C. M. (2015) · Immunity · doi:10.1016/j.immuni.2015.10.012 · Cited by 153
Perry, J. S. A., Han, S., Xu, Q., Herman, M. L., Kennedy, L. B., Csako, G., & Bielekova, B. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004140 · Cited by 152 · cited 1×
“Daclizumab modulates ILC responses by decreasing the number of ILCs by modifying the cells’ phenotypes and shifting the cells toward a NK cell lineage [112].”
BackgroundLymphoid follicles in (very) severe COPD: beneficial or harmful?
Brusselle, G. G., Demoor, T., Bracke, K. R., Brandsma, C.-A., & Timens, W. (2009) · European Respiratory Journal · doi:10.1183/09031936.00150208 · Cited by 151 · cited 10×
“Importantly, IL-5 and IL-13 were produced by ILC2s and are responsible for COPD exacerbation [111].”
BackgroundInfluentialNakagawa, H., Niiro, H., & Ootaki, K. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.10.009 · Cited by 147
Papp, K. A., Reid, C., Foley, P. A., Sinclair, R. D., Salinger, D. H., Williams, G., Dong, H., Krueger, J. G., Russell, C. B., & Martin, D. A. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.163 · Cited by 143
Mielke, L. A., Groom, J. R., Rankin, L. C., Seillet, C., Masson, F., Putoczki, T., & Belz, G. T. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301228 · Cited by 139
Liu, T., Wu, J., Zhao, J., Wang, J., Zhang, Y., Liu, L., Cao, L., Liu, Y., & Dong, L. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.09.016 · Cited by 134
IL-22 Is Produced by Innate Lymphoid Cells and Limits Inflammation in Allergic Airway Disease
Taube, C., Tertilt, C., Gyülveszi, G., Dehzad, N., Kreymborg, K., Schneeweiss, K., Michel, E., Reuter, S., Renauld, J.-C., Arnold-Schild, D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021799 · Cited by 134 · cited 1×
“maintenance of lung epithelial cell function and in the negative regulation of lung inflammation [67, 68].”
BackgroundCritical Role of p38 and GATA3 in Natural Helper Cell Function
Furusawa, J.-I., Moro, K., Motomura, Y., Okamoto, K., Zhu, J., Takayanagi, H., Kubo, M., & Koyasu, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300379 · Cited by 134 · cited 1×
“Furthermore, GATA3 is required for the functional maturation and maintenance of ILC2s [41–44], and Bcl11b serves as a upstream regulator of the transcriptional factor Gfi1 to maintain Gfi1 expression in mature ILC2s.”
BackgroundRoos, A. B., Sandén, C., Mori, M., Bjermer, L. H., Stämpfli, M. R., & Erjefalt, J. S. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201410-1861oc · Cited by 128
Innate lymphoid cells: critical regulators of allergic inflammation and tissue repair in the lung
Monticelli, L. A., Sonnenberg, G. F., & Artis, D. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.03.012 · Cited by 109 · cited 1×
“spiratory tract mucosal sites is critical to limit exposure to physiological and immunological stimuli [64, 65].”
BackgroundSecukinumab failure in Crohn's disease: the yeast connection?
Colombel, J., Sendid, B., Jouault, T., & Poulain, D. (2012) · Gut · doi:10.1136/gutjnl-2012-304154 · Cited by 93
Murine B1 B Cells Require IL-5 for Optimal T Cell-Dependent Activation
Erickson, L. D., Foy, T. M., & Waldschmidt, T. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1531 · Cited by 75 · cited 1×
“IL-5 and IL-6 regulate B cell antibody production and self-renewal of B1 cells [88–90].”
BackgroundRuiter, B., Patil, S. U., & Shreffler, W. G. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12568 · Cited by 73 · cited 2×
“A clinical study revealed that Vitamin D can inhibit cytokine production and integrin α4β7 expression in human ILCs [113].”
BackgroundRhinovirus-Induced Exacerbations of Asthma and COPD
Hershenson, M. B. (2013) · Scientifica · doi:10.1155/2013/405876 · Cited by 65 · cited 1×
“IL-13 mRNA levels are increased ~30-fold in sputum eosinophils and endothelial cells in AECOPD patients compared to normal control subjects [110].”
BackgroundHagelberg, T. (1951) · PubMed · Cited by 64
Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapy
Bowman, E. P., Chackerian, A. A., & Cua, D. J. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000224818.42729.67 · Cited by 58
NFIL3-Deficient Mice Develop Microbiota-Dependent, IL-12/23–Driven Spontaneous Colitis
Kobayashi, T., Steinbach, E. C., Russo, S. M., Matsuoka, K., Nochi, T., Maharshak, N., Borst, L. B., Hostager, B., Garcia-Martinez, J. V., Rothman, P. B., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301819 · Cited by 58 · cited 1×
“The differentiation of ILCs from CLPs requires transcriptional factors, including inhibitor of DNA binding 2 (Id2), nuclear factor interleukin-3 regulated (NFIL3), and thymocyte selection-associated highmobility group box protein (TOX) [2, 3, 16, 19–24].”
BackgroundGroup 2 Innate Lymphoid Cells in the Lung
Drake, L. Y., & Kita, H. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800147-9.00001-7 · Cited by 49 · cited 1×
“Other studies showed that FALC-derived ILC2s support the self-renewal and expansion of B1 and B2 cells and enhance the production of the IgA, IgM, IgG1, and IgE antibody classes [34, 71, 72, 91].”
BackgroundNot all monoclonals are created equal – Lessons from failed drug trials in Crohn's disease
Kaser, A. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.04.005 · Cited by 42 · cited 1×
“In some cases, anti-IL-17 therapy resulted in increased susceptibility to fungal infections and enhanced disease [120–123].”
BackgroundWu, C. A., Puddington, L., Whiteley, H. E., Yiamouyiannis, C. A., Schramm, C. M., Mohammadu, F., & Thrall, R. S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2798 · Cited by 38 · cited 3×
“In a mouse study, ILC accumulation in lung tissue was observed during acute exacerbations of COPD (AECOPD) [106].”
BackgroundRole of Innate Lymphoid Cells in Lung Disease.
Marashian, S. M., Mortaz, E., Jamaati, H., Alavi-Moghaddam, M., Kiani, A., Abedini, A., Garssen, J., Adcock, I. M., & Velayati, A. A. (2015) · PubMed · Cited by 30
Rohde, G. G. U., Gevaert, P., Holtappels, G., Fransen, L., Borg, I., Wiethege, A., Arinir, U., Tavernier, J. H., Schultze‐Werninghaus, G., & Bachert, C. (2004) · International Archives of Allergy and Immunology · doi:10.1159/000080043 · Cited by 25 · cited 1×
“Importantly, IL-5 and IL-13 were produced by ILC2s and are responsible for COPD exacerbation [111].”
Background
Cited by
The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis
Desai, O., Winkler, J., Minasyan, M., & Herzog, E. L. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00043 · Cited by 314
“ILCs in the lung interact with epithelial cells, natural killer T cells, and myeloid cells to form an immune system network (122).”
BackgroundMechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection
Curran, C. S., Bolig, T., & Torabi-Parizi, P. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201705-1043so · Cited by 182
Sex Hormones Regulate Innate Immune Cells and Promote Sex Differences in Respiratory Virus Infection
Kadel, S., & Kovats, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01653 · Cited by 181
“In homeostasis, ILC2s are the predominant ILC subset in the murine lung (102), and both ILC2s and ILC3s are predominant in human lung (103).”
BackgroundThe Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the Lung
Wirsdörfer, F., & Jendrossek, V. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00591 · Cited by 125
“The present knowledge on ILC has nicely been summarized in two recent reviews with a focus on their roles in the lung tissue (94, 95).”
BackgroundAirway Basal Cells, Protectors of Epithelial Walls in Health and Respiratory Diseases
Ruysseveldt, E., Martens, K., & Steelant, B. (2021) · Frontiers in Allergy · doi:10.3389/falgy.2021.787128 · Cited by 112
Metadata
- Authors
- Lai, D.-M., Shu, Q., & Fan, J.
- Affiliations
- Children's Hospital of Zhejiang University (CN)
- University of Pittsburgh (US)
- Corresponding author
- Fan, Jie
- ORCID
- Venue
- Military Medical Research
- Publisher
- Elsevier BV
- Published
- 2016-08-19
- Volume
- 3
- Issue
- 1
- Pages
- 25-25
- ISSN
- 2054-9369 (ISSN-L)
- PMC
- PMC4992280
- OpenAlex
- W2514325364
- Cited by
- 45
- References
- 127
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 5 · 2022: 2 · 2021: 6 · 2020: 8 · 2019: 2 · 2018: 10 · 2017: 5 · 2016: 1
- FWCI
- 0.58
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- Military Medical Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- USA National Institutes of Health Grant (R01-HL076179, R56-HL-123882)
- USA VA Merit Award (1I01BX002729)
- Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Keywords
- innate lymphoid cells, lung, lung disease, helminthiasis, allergic airway inflammation, airway hyperresponsiveness, mucosal immunity, tissue homeostasis, immune regulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.